Navigation Links
Moleac Launches NeuroAid10(TM) in the United States
Date:3/6/2008

Supplement to help support Neurological Function Now Available in the US

SINGAPORE, March 6 /Xinhua-PRNewswire/ -- Singapore-based Moleac today launched a new product called NeuroAid10(TM) in the US market to support patients' neurological functions. NeuroAid10(TM) is derived from NeuroAid(TM) and is a combination of ten all-natural ingredients. Moleac is a global biopharmaceutical company that brings together the best of Asian and Western medicine.

Since its launch in 2000, NeuroAid(TM) has been used by 200,000 stroke survivors every year in Asia alone. In addition, a growing number of Americans have already started using NeuroAid(TM) regularly with positive results on their neurological functions.

The clinical data obtained with NeuroAid(TM) on recovery several months after a stroke has triggered large interest in the neurology community. In October 2007, enrollment began for a multi-center, double-blind, placebo- controlled, randomized trial. This aims to evaluate the efficacy of NeuroAid(TM) in reducing neurological deficit and improving independence in patients in rehabilitation, with treatment starting within 48 hours of a stroke. "The CHIMES Stroke Study is ground-breaking for the medical industry as the largest clinical trial on stroke recovery and the first time any TCM product has been assessed on this wide a scale outside China," said Professor Geoffrey Donnan, President World Stroke Organization, who chairs the study data and safety monitoring committee.

NeuroAid(TM) is already commonly used in several countries. "As we received an increasing number of requests from individuals in US to make NeuroAid(TM) available locally, we have engineered a new formulation which is marketed as Neuroaid10TMin the US, a dietary supplement to help support the neurological functions. NeuroAid10(TM) is an herbal natural dietary supplement, containing the 10 main ingredients of NeuroAid(TM), carefully selected and manufactured with the same stringent process as NeuroAid(TM)," said David Picard, CEO Moleac.

NeuroAid10(TM) is marketed in the US as an herbal dietary supplement with the indication to help support neurological functions.

Neurological functions involve the brain and the nervous system. The nervous system connects the entire human body, relaying information back and forth between the brain and the muscles, skin and key organs, allowing actions such as movement, and sensations such as pain. The smooth transmission of information between the brain and the rest of the body is therefore essential for daily activities such as walking, speaking or thinking, and can only occur when neurological functions are healthy and strong.

Ruth Lycke, a stroke survivor and the author of "Hope, Help and Healing", said, "I am thrilled to see NeuroAid10(TM) now available locally after having benefited myself from the treatment in China."

NeuroAid10(TM) does not contain any of the animal based ingredients of NeuroAid(TM) which were considered as secondary in the original formulation. "We will work with health authorities around the world to make NeuroAid(TM) available in international markets over the coming years," said Picard.

Moleac has now established a robust distribution system in the US with Suresource. The product can be purchased at http://www.neuroaid10.com or at http://www.amazon.com .

About NeuroAid10(TM)

NeuroAid10(TM) is a Dietary Supplement that provides support for neurological functions. It is a combination of ten all ingredients from the Chinese medicinal pharmacopoeia, formulated according to international Good Manufacturing Practice (GMP) standards. It is marketed internationally by Moleac. For more information visit http://www.neuroaid10.com or by calling +1-800-421-1223.

About Moleac

Moleac is a biopharmaceutical company based in the Republic of Singapore;. Moleac identifies promising medicines and develops them for broad distribution. Focusing on patients' greatest needs and specific unmet medical needs, Moleac drives research, development and registration for a pipeline of drugs and devices in various stages of development.

DISCLOSURE NOTICE: The information contained in this release is as of March 20,2008. Moleac assumes no obligation to update any forward-looking statements contained in this release as the result of new information or future events or developments. This release contains forward-looking information about the potential benefits of NeuroAid(TM) and NeuroAid10(TM) that involves substantial risks and uncertainties.

Contact:

Moleac

Tel: +65-6478-9431 or +1-203-404-8258

Email: news@moleac.net


'/>"/>
SOURCE Moleac
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, ... the "Company"), announced that on January 14, 2017 the ... under which the Company will terminate certain employees associated ... Diagnostics, Inc.  The Company commenced terminations on January 16, ... 30 days.  The Company may pay severance benefits in ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... PUNE, India , Jan. 19, 2017  Market Research Future ... The Global Market for Liquid Biopsy is growing rapidly and expected ... period. Market Highlights ... The Global Liquid Biopsy Market has been assessed as ... high growth figures and boom in the coming future. There has ...
Breaking Biology Technology:
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... , Dec. 15, 2016 Advancements ... experience, health wellness and wellbeing (HWW), and ... in three new passenger vehicles begin to ... gesture recognition, heart beat monitoring, brain wave ... facial monitoring, and pulse detection. These will ...
Breaking Biology News(10 mins):